Neurofilament and tubulin gene expression in progressive experimental diabetes
Open Access
- 1 November 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 122 (11) , 2109-2118
- https://doi.org/10.1093/brain/122.11.2109
Abstract
In human and experimental diabetes, the relationship between molecular abnormalities in perikarya of sensory neurons and structural abnormalities in their distal axons is largely unexplored. In this study we examined neurofilament (Nf) and tubulin messenger RNA (mRNA) expression and their incorporation into distal sensory axons during progressive streptozotocin-induced diabetes in rats. After 2 and 6 months of diabetes, we measured mRNA levels of all three Nf subunits, B50 [growth associated protein-43 (GAP-43)] and α-tubulin in L4–L6 dorsal root ganglia using Northern analysis. The same animals underwent morphometric studies of myelinated fibres by light microscopy and quantitative analysis of Nf and microtubule numbers and density within sural myelinated and unmyelinated axons. Multifibre in vivo sensory and motor conduction nerve recordings confirmed slowing of conduction velocities in diabetic rats indicating experimental neuropathy. mRNA levels for the three Nf subunits, B50 (GAP-43) and α-tubulin were unchanged from controls at 2 months, but were decreased by 26–46% at 6 months. These changes accompanied declines in Nf numbers and densities within large myelinated sensory axons, and Nf numbers in unmyelinated fibres by 6 months. Microtubule numbers and densities were similarly reduced in large myelinated axons, and microtubule numbers reduced in small myelinated and unmyelinated axons in diabetes at 6, but not 2 months. Axonal atrophy was observed in unmyelinated fibres at 6 months. Our findings indicate that decreased mRNA expression of cytoskeletal proteins in sensory neurons accompanies a reduction in their incorporation into distal axons. These changes imply that there is a direct link between pathological changes in the sensory neuron and alterations of its distal branches from experimental diabetes. The changes in gene expression in diabetes are unique and differ from those that develop after axotomy.Keywords
This publication has 28 references indexed in Scilit:
- Neurotrophins and Other Growth Factors in Diabetic NeuropathySeminars in Neurology, 1996
- Neurotrophins and nerve injury in the adultPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1996
- Axonal atrophy in aging is associated with a decline in neurofilament gene expressionJournal of Neuroscience Research, 1995
- GAP‐43 gene expression is increased in anterior horn cells of amyotrophic lateral sclerosisAnnals of Neurology, 1992
- Postnatal increases in neurofilament gene expression correlate with the radial growth of axonsJournal of Neurocytology, 1991
- Alterations in levels of mRNAs coding for neurofilament protein subunits during regenerationExperimental Neurology, 1990
- Slow Axonal Transport Impairment of Cytoskeletal Proteins in Streptozociti-Induced Diabetic NeuropathyJournal of Neurochemistry, 1989
- Retardation in the slow axonal transport of cytoskeletal elements during maturation and agingNeurobiology of Aging, 1989
- Early and late appearance of neurofilament phosphorylated epitopes in rat nervous system development: In vivo and in vitro study with monoclonal antibodiesJournal of Neuroscience Research, 1988
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987